Screener
10x Genomics, Inc. TXG Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s total liabilities?
- 10x Genomics, Inc. (TXG) reported total liabilities of $204.52M in Q2 2026.
- How has 10x Genomics, Inc.'s total liabilities changed year-over-year?
- 10x Genomics, Inc.'s total liabilities decreased by 1.1% year-over-year, from $206.69M to $204.52M.
- What is the long-term trend for 10x Genomics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s total liabilities has grown at a 5.2% compound annual growth rate (CAGR), from $190.27M to $245.04M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about 10x Genomics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude